Trypanosoma cruzi: Genetic Group with Peculiar Biochemical and Biological Behavior

Memorias do Instituto Oswaldo Cruz

Volumn 98, Issue 5, 2003, Pages 649-654

  Gomes, Mônica Lúcia ^a   Toledo, Max Jean De Ornelas ^a   Nakamura, Celso Vataru ^a   Bittencourt, Nilza De Lucas Rodrigues ^a   Chiari, Egler ^b   Marques De Araújo, Silvana ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Biological characteristics; Glycoconjugates; Randomly amplified polymorphic DNA (RAPD); Simple sequence repeat anchored polymerase chain reaction amplified (SSR PCR); Trypanosoma cruzi

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; GENETIC CORRELATION; GENETIC VARIABILITY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITE LOCALIZATION; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED MICROSATELLITE; SPECIES COMPARISON; STRAIN IDENTIFICATION; TRYPANOSOMA CRUZI; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; DRUG SENSITIVITY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; PHYSIOLOGY; RANDOM AMPLIFIED POLYMORPHIC DNA; VARIABLE NUMBER OF TANDEM REPEAT;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; GLYCOCONJUGATE; NITROIMIDAZOLE DERIVATIVE; PROTOZOAL DNA;

ANIMALS; BEHAVIOR, ANIMAL; DNA, PROTOZOAN; GENOTYPE; GLYCOCONJUGATES; HUMANS; MINISATELLITE REPEATS; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0142259231     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762003000500011     Document Type: Article

References (32)

1. Andrade SG, Magalhães JB 1997. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with data and experimental pathology. Rev Soc Bras Med Trop 30: 27-35.
2. Barnabé B, Neubauer K, Solari A, Tibayrenc M 2001. Trypanosoma cruzi: presence of the two major phylogenetic lineages and of several lesser discrete typing units (DTUs) in Chile and Paraguay. Acta Trop 78: 127-137.
3. Branquinha MH, Meirelles MNL, Lopes A, Moreira C, Vermelho AB 1995. Use of glycoconjugates for trypanosomatid taxonomy. Current Microbiol 30: 77-82.
4. Brener Z 1962. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4: 389-396.
5. Bordier C 1981. Phase separation of integral membrane protein in Triton X-114 solution. J Biol Chem 156: 1604-1607.
6. Carneiro M, Romanha AJ, Chiari E 1991. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Mem Inst Oswaldo Cruz 88: 387-393.
7. Chiari E, Dias JCP, Lana M, Chiari CA 1989. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev Soc Bras Med Trop 22: 19-23.
8. Chiari E, Marques de Araújo S, Carneiro M 1980. Meios empobrecidos em nutrientes na diferenciação epimastigota- tripomastigota do Trypanosoma cruzi. VII Reunião Anual em Pesquisa Básica em Doença de Chagas, abst. BI-41.
9. Dias JCP 1992. Epidemiology of Chagas' disease. In S Wendel, Z Brener, ME Camargo, A Rassi (eds), Chagas' Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine, Sociedade Brasileira de Hematologia e Hemoterapia, São Paulo, p. 49-80.
10. Diego JA, Palau MT, Gamallo C, Penin P 1998. Relationships between histopathological findings and phylogenetic divergence in Trypanosoma cruzi. Trop Med Int Health 3: 222-233.
11. Dvorak JA 1984. The natural heterogeneity of Trypanosoma cruzi: biological and medical implications. J Cel Biochem 24: 357-371.
12. Filardi L, Brener Z 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Trans R Soc Trop Med Hyg 81: 755-759.
13. Giovanni-de-Simone S, Bonaldo MC, Pinho RT, Pontes-de-Carvalho LC, Galvão-Castro B, Goldenberg S 1988. A study on the amphiphilic proteins of three Trypanosoma cruzi populations. Brazilian J Med Biol Res 21: 435-443.
14. Gomes ML, Macedo AM, Pena SDJ, Chiari E 1998. Genetic relationships between Trypanosoma cruzi strains isolated from chronic chagasic patients in Southern Brazil as revealed by RAPD and SSR-PCR analysis. Acta Trop 69: 99-109.
15. Kumar S, Koichiro T, Nei M 1993. Mega: Molecular Evolutionary Genetics Analysis, version 1.0, The Pennsylvania State University Park, PA 16802.
16. Laurent JP, Barnabé C, Quesney V, Noel S, Tibayrenc M 1997. Impact of clonal evolution on the biological diversity of Trypanosoma cruzi. Parasitology 114: 213-218.
17. Laemmli UK 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
18. Macedo AM, Martins MS, Chiari E, Pena SDJ 1992. DNA fingerprinting of Trypanosoma cruzi: a new tool for characterization of strains and clones. Mol Biochem Parasitol 55: 147-154.
19. Miles MA, Toye PJ, Oswald SC, Godfrey DG 1977. The identification by isoenzyme patterns of two distinct strain-groups of Trypanosoma cruzi, circulating independently in rural area of Brazil. Trans R Soc Trop Med Hyg 71: 217-225.
20. Momen H 1999. Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature. Mem Inst Oswaldo Cruz 94 (Suppl. 1): 181-184.
21. Moody S, Becker S, Nuchamowitz Y, Mirelman D 1997. Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids. Parasitology 114: 95-104.
22. Morel CM, Chiari E, Camargo EP, Mattei DM, Romanha AJ, Simpson L 1980. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 77: 6810-6814.
23. Muskus CE, Marin Villa M 2002. Metacyclogenesis: a basic process in the biology of Leishmania. Biomedica 22: 167-77.
24. Oliveira RP, Macedo AM, Chiari E, Pena SDJ 1997. An alternative approach to evaluating the intraspecific genetic variability of parasites. Parasitol Today 13: 196-200.
25. Revollo S, Oury B, Laurent JP, Barnabé C, Quesney V, Carrière V, Noel S, Tibayrenc M 1998. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 89: 30-39.
26. Spath GF, Epstein L, Leader B, Singer SM, Avila HA, Turco SJ, Beverley SM 2000. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 97: 9258-63.
27. Steindel M, Neto ED, Menezes CLP, Romanha AJ, Simpson AJG 1993. Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Mol Biochem Parasitol 60: 71-80.
28. Tibayrenc M, Ayala FJ 1988. Isozyme variability in Trypanosoma cruzi, the agent of Chagas' disease: genetical, taxonomical, and epidemiological significance. Evolution 42: 277-292.
29. Tibayrenc M, Neubauer K, Barnabé C, Guerrini F, Skarecky D, Ayala FJ 1993. Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proc Natl Acad Sci USA 90: 1335-1339.
30. Tibayrenc M, Ward P, Moya A, Ayala F J 1986. Natural populations of Trypanosoma cruzi, the agent of Chagas' disease, have a complex multiclonal structure. Proc Natl Acad Sci USA 83: 115-119.
31. Toledo MJO, Bahia MT, Carneiro CM, Martins-Filho OA, Tibayrenc M, Barnabé C, Tafuri WL, Lana M 2003. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrob Agents Chemother 47: 223-230.
32. Toledo MJO, Lana M, Carneiro CM, Bahia MT, Machado-Coelho GLL, Veloso VM, Barnabé C, Tibayrenc M, Tafuri WL 2002. Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Exp Parasitol 100: 161-172.